Clinical Trials Browser

Astrocytoma, Ganglioneuroma, Glioblastoma, Glioma, Histiocytosis, Langerhans-Cell, Neuroblastoma, Neurofibromatosis 1, Oligodendroglioma, Ganglioglioma, Neurocytoma, Neurofibroma, Plexiform

NCT05161195 2026-04-02

Roll-over Study to Allow Continued Access to Ribociclib

Phase 4 Active not recruiting

134 enrolled

Breast

Breast Neoplasms

NCT05252585 2026-04-02

A Phase IV Study of Safety and Efficacy of Everolimus in Taiwanese Patients With Tuberous Sclerosis Complex Who Have Renal Angiomyolipoma (TSC-AML)

Phase 4 Active not recruiting

4 enrolled

Tuberous Sclerosis, Angiomyolipoma

NCT05754528 2026-04-02

REaCT-TEMPO

Phase 4 Active not recruiting

240 enrolled

Breast

Breast Neoplasms

NCT01742299 2026-04-01

Study to Allow Access to Imatinib for Patients Who Are on Imatinib Treatment in a Novartis-sponsored Study and Are Benefiting From the Treatment as Judged by the Investigator

Phase 4 Active not recruiting

155 enrolled

GastrointestinalSarcoma

Gastrointestinal Stromal Tumors

NCT05160922 2026-03-30

Crizotinib Continuation Clinical Study

Phase 4 Active not recruiting

27 enrolled

LymphoidPlasma cellThoracic

Carcinoma, Non-Small-Cell Lung, Granuloma, Plasma Cell, Lymphoma, Large-Cell, Anaplastic

NCT03144206 2026-03-27

Hyperbaric Oxygen Therapy for Soft Tissue Sarcoma Pilot Study

Phase 4 Active not recruiting

20 enrolled

Sarcoma

NCT04033081 2026-03-23

Registry of Sarcoma Patients Treated With Permanently Implantable LDR CivaSheet®

Phase 4 Active not recruiting

100 enrolled

Sarcoma

NCT04726501 2026-03-19

CCCG-HD-2018 for Children and Adolescents With Newly Diagnosed Hodgkin Lymphoma

Phase 4 Active not recruiting

200 enrolled

Lymphoid

Hodgkin Disease

NCT03173092 2026-03-18

A Study of Ixazomib (NINLARO®) in Combination With Lenalidomide and Dexamethasone (IRD) for the Treatment of Participants With Multiple Myeloma (MM)

Phase 4 Active not recruiting

141 enrolled

Plasma cell

Multiple Myeloma

NCT05044819 2026-03-17

Assessment of Potential for Chronic Liver Injury in Participants Treated With Epidiolex (Cannabidiol) Oral Solution

Phase 4 Active not recruiting

154 enrolled

Epilepsies, Myoclonic, Liver Cirrhosis, Tuberous Sclerosis, Lennox Gastaut Syndrome

NCT02386800 2026-03-16

CINC424A2X01B Rollover Protocol

Phase 4 Active not recruiting

279 enrolled

MyeloidOther hematologic neoplasm

Bronchiolitis Obliterans Syndrome, Graft vs Host Disease, Polycythemia Vera, Thalassemia, Leukemia, Myeloid, Acute, Primary Myelofibrosis

NCT05864846 2026-03-12

EpiCom

Phase 4 Active not recruiting

79 enrolled

Behavior, Seizures, Tuberous Sclerosis

NCT05689671 2026-03-10

ANTELOPE

Phase 4 Active not recruiting

136 enrolled

Thoracic

Non-Small Cell Lung Cancer Metastatic

NCT06049134 2026-03-09

Immunogenicity and Clinical Efficacy of 20-valent Pneumococcal Conjugate Vaccine (PCV20) in Lymphoma Survivors After Treatment With Anti-CD20 Therapy

Phase 4 Active not recruiting

30 enrolled

Lymphoid

Lymphoma

NCT04701151 2026-03-03

NORTH-REG Dwell-Time Study

Phase 4 Active not recruiting

314 enrolled

Side Effect of Drug

NCT03016741 2026-02-24

Cognitive Effects of Androgen Receptor Directed Therapies for Advanced Prostate Cancer

Phase 4 Active not recruiting

100 enrolled

Genitourinary

Dementia, Prostatic Neoplasms, Cognitive Dysfunction, Prostatic Neoplasms, Castration-Resistant

NCT07224035 2026-02-17

Helicobacter Pylori Screening and Treatment in the At-risk South Florida Community- AIM 1

Phase 4 Active not recruiting

500 enrolled

Gastrointestinal

Stomach Neoplasms

NCT07224048 2026-02-17

Helicobacter Pylori Screening and Treatment in the At-risk South Florida Community-AIM 2

Phase 4 Active not recruiting

75 enrolled

Gastrointestinal

Stomach Neoplasms

NCT02875314 2026-02-12

HeadStart4: Newly Diagnosed Children (<10 y/o) With Medulloblastoma and Other CNS Embryonal Tumors

Phase 4 Active not recruiting

250 enrolled

CNS

Medulloblastoma

NCT06627530 2026-02-11

COAction

Phase 4 Active not recruiting

144 enrolled

Genitourinary

Prostatic Neoplasms

NCT02162849 2026-02-09

Reward Sensitivity and Pharmacotherapy for Smoking Cessation

Phase 4 Active not recruiting

204 enrolled

Smoking Cessation, Tobacco Use Cessation

NCT04206813 2026-01-27

An Exploratory Open-Label Clinical Trial Evaluating the Immunogenicity of the 9-valent 2-dose HPV Vaccination Regimen

Phase 4 Active not recruiting

352 enrolled

Papillomavirus Infections

NCT05634720 2026-01-26

Hepatic Artery Chemotherapy for Patients With Localized Pancreas Cancer

Phase 4 Active not recruiting

20 enrolled

Gastrointestinal

Pancreatic Ductal Adenocarcinoma

NCT04928261 2026-01-22

Evaluating 6-months of HER2-targeted Therapy in Patients With HER2 Positive Early-stage Breast Cancer That Achieve a Pathological Complete Response to Neoadjuvant Systemic Therapy

Phase 4 Active not recruiting

52 enrolled

Breast

Breast Neoplasms, Cardiotoxicity